Skip to main content

Table 1 Patient characteristics

From: Visual outcome is similar in optic neuritis patients treated with oral and i.v. high-dose methylprednisolone: a retrospective study on 56 patients

  All patients (n = 56) Oral (n = 28) i.v. (n = 28)
Gender (female/male) 42/14 20/8 22/6
Median age (range) (years)   33 (23 to 60) 35 (18 to 60)
Median duration of symptoms before treatment (range) (days)   7 (1 to 35) 7 (1 to 30)
Median total dose MP (range) (grams)   3.0 (1.5 to 5) 3.0 (2.8 to 6)
Median treatment duration (range) (days)   3 (3 to 5) 3 (3 to 6)
Median follow-up time (range) (weeks)   9 (4 to 24) 9 (4 to 24)
Multiple sclerosis before treatment (number of patients) 13 5 8
Undergoing disease-modifying therapy for MS (number of patients) 8 2 6
Previous ON in other eye (number of patients) 8 5 3